August 2020 - PsychedelicNewsWire (PNW)

MondayAug 31, 2020 12:29 pm

Cybin Corp. at Forefront of Change in Psilocybin-Based Treatments

Company focused on furthering R&D of psilocybin-based medications Cybin believes psychedelic substances derived from mushrooms can work as boosters for brain Psilocybin shows promise for an array of mental health issues Cybin Corp. is a leading life-science company focused on psychedelic and nutraceutical products to support various psychiatric and neurological conditions. The company is engaged in clinical trials, through a partnership with the Toronto Centre for Psychedelic Science (“TCPS”) to gain regulatory approval for psilocybin and other psychedelic products (http://ibn.fm/RgpQc). In the 1940s, the study of psychedelic drugs for the treatment of mental health conditions began with the discovery of LSD.…

MondayAug 31, 2020 11:05 am

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in White Label Market

Company’s Standard Processing License pending approval from Health Canada After licensing approval, Pure Extracts will be launching white label production as part of core services Pure Extracts facility designed to produce high-quality, high-purity formulations on a commercial scale Pure Extract Technologies, a Canadian plant-based extraction company operating in the functional medicinal mushrooms space, is preparing to become a leading contender in the white labeling space. The Company’s Standard Processing License is currently pending approval from Health Canada; upon approval the Company will be launching white label production as part of its core services. As an expert in the extraction field,…

MondayAug 31, 2020 10:00 am

Psychedelics, Ego Death and the Brain

Contemporary neuroscience has shown that psychedelics like psilocybin, LSD and ayahuasca significantly decrease activity in the brain’s DMN (default mode network). This decline in DMN action in a way reboots one’s brain and is associated with one of the lasting therapeutic effects of psychedelic substances. The DMN is an interlinked group of brain regions that are linked to introspective functions and internally directed thoughts like self-criticism and self-reflection. The practical connections that constitute the DMN grow between birth and adulthood. It is not until the age of five that a child develops ‘ego’ or a stable sense of narrative self.…

FridayAug 28, 2020 12:15 pm

Congressman Helps Raise Money to Legalize Psilocybin Mushroom Therapy

The representative for Oregon's 3rd Congressional district Earl Francis Blumenauer, who is a chief advocate for cannabis reform, formally announced his support of Oregon’s initiative to legalize psilocybin mushrooms to be used for therapeutic purposes. He is also helping to raise money for the company. He stated in a mass email that he fully supported the measure as it addresses mental health which is key issue in the community, in a responsible and innovative way. Additionally, he stated that the legalization of psilocybin therapy was an important tool that deserved everyone’s support. The measure in question, Measure 109, provides residents…

ThursdayAug 27, 2020 2:45 pm

Mental Health: The Second Pandemic. Is Psychedelic-Assisted Therapy the Answer?

Largely due to the COVID-19 pandemic and the lockdowns imposed in various jurisdictions around the world, mental health issues have become the new topic of discussion. According to the Journal of the American Psychiatric Nurses Association, the psychological torrent from COVID-19 is likely to develop into a completely distinct pandemic of its own. Other organizations such as the United Nations and World Health Organization have also cited the possible mental health emergency as something that should not be ignored. A study carried out by JAPNA highlights the need for new and better mental health interpositions as a way to prepare…

WednesdayAug 26, 2020 10:00 am

The Multidisciplinary Association for Psychedelic Studies Raises $30M to Complete MDMA Study

On Thursday, the Multidisciplinary Association for Psychedelic Studies (“MAPS”) reported it had collected $30 million in donations, which will be used in the completion of a study on the use of MDMA to help remedy PTSD, or post-traumatic stress disorder. MAPS stated that the funds would be used in the MDMA trials, which is a Phase 3 study, in a bid to secure approval from the FDA. The FDA had before identified MDMA, commonly referred to as ecstasy, as “breakthrough therapy” using earlier trials as their basis. In total, an estimated 2,500 individuals donated to help MAPS get to their…

TuesdayAug 25, 2020 11:16 am

Psychedelics Decriminalization Petition Awaits Response from the Canadian Government

A petition that called for the decriminalization of psychedelics garnered about 15,000 signatures surpassing the required 500 signatures and will be read formally in the House of Commons after sessions resume on September 23. It talks about the different uses of entheogen plants and fungi as well as the substances’ therapeutic potential. After it’s been introduced, the government has 45 days to put out a response. The MP Paul Manly of the Green Party who sponsored the petition revealed bigger plans for the bill, saying that he’d continue his support while pushing for decriminalization of possession of all drugs that…

MondayAug 24, 2020 10:00 am

Oakland Activists Unveil Guidelines for Planned Psychedelic Healing Ceremonies Upon Prospective Legalization

Lawmakers in Oakland have achieved a major milestone in the use of psychedelics when they spearheaded a successful drive to decriminalize plant and fungi-based psychedelics. The move allows members of the public to consume ayahuasca and psilocybin mushrooms without fear of landing in jail. In their next push to legalize psychedelic healing ceremonies, the psychedelics activists have rolled out a myriad of safety guidelines that participants in entheogenic healing ceremonies will follow once legalization occurs. The healing ceremonies involve the use of entheogenic substances believed to have healing capabilities. So far, the practice awaits legislation to have legal backing. Decriminalize…

FridayAug 21, 2020 2:00 pm

Eleusis Sheds Light on the Asthma-Fighting Properties of Psychedelics

The medical community has always had keen interest in psychedelics, such as LSD, for their anti-inflammatory properties. However, the stigma associated with these substances, together with the prohibitive laws in force, have made the therapeutic exploitation of psychedelics a difficult undertaking. The recent interest directed towards psychedelics has allowed Eleusis Ltd., a psychedelics company, to investigate the different psychedelics in order to find out which ones have potent anti-inflammatory attributes. The researchers employed by the company looked at about 21 psychedelics which target a specific serotonin receptor (5-HT2A). When this receptor is activated, anti-inflammatory effects are observed in asthmatics. The…

ThursdayAug 20, 2020 9:00 am

Psycholytic vs. Psychedelic Therapy

With psychedelic-assisted therapy now getting airtime on major media outlets and channels like CNN and Bloomberg, it is safe to say that psychedelics have now gone mainstream. However, the media doesn’t provide as much detailed information as the public needs since the media is driven by the lure of the shareable sound bite and the sensational headline. For this reason, many members of the public may use the term psychedelic therapy when referring to psycholytic therapy, yet these concepts aren’t interchangeable. To clear this confusion, we have prepared the following analysis of these related forms of therapy. Psychedelic Therapy In…

News and publishing service for psychedelic related companies

Contact us: 415.949.5050

Month: August 2020